A recent study highlighted a link between the use of fluoroquinolones, a commonly prescribed class of antibiotic, and the risk of aortic and mitral regurgitation. Consultant360 spoke with Mahyar Etminan,...
In this podcast, Zubin Modi, MD, from the University of Michigan Medical School, discusses his research on the risk of CVD in young adults with end-stage renal disease.
Samantha Ellingson, PharmD, BCPS, and Timothy H. Self, PharmD—Series Editor
Samantha Ellingson, PharmD, BCPS, and Timothy H. Self, PharmD—Series Editor
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
Brendan M. Everett, MD, MPH, from Harvard Medical School answers our questions about his session at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease conference.
Dr Laxmi Mehta, from Ohio State University, talks about coronary disease treatments for pregnant women, gives an example of a challenging patient case, and elaborates on the role of statins in the treatment...
